Santen Pharmaceutical Co., Ltd. (TYO: 4536)

Santen Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	84,441	94,582	57,903	83,014	62,888	91,430
Cash & Short-Term Investments	84,441	94,582	57,903	83,014	62,888	91,430
Cash Growth	30.46%	63.35%	-30.25%	32.00%	-31.22%	29.15%
Accounts Receivable	71,124	90,539	107,165	99,591	95,992	86,999
Other Receivables	-	-	60	-	-	-
Receivables	71,124	90,539	107,225	99,591	95,992	86,999
Inventory	53,060	43,185	39,352	37,141	41,575	35,282
Other Current Assets	9,853	7,833	8,846	9,680	5,776	4,845
Total Current Assets	218,478	236,139	213,326	229,426	206,231	218,556
Property, Plant & Equipment	71,164	71,576	66,173	56,287	39,489	35,601
Long-Term Investments	29,955	33,400	42,560	40,944	40,933	32,661
Goodwill	-	8,303	7,385	13,715	26,858	22,127
Other Intangible Assets	79,411	75,516	88,924	116,502	86,018	97,723
Long-Term Deferred Tax Assets	10,076	10,765	2,810	3,103	2,824	2,100
Other Long-Term Assets	1	-	1	-1	-	-
Total Assets	409,085	435,699	421,179	459,976	402,353	408,768
Accounts Payable	41,599	43,531	44,945	41,185	38,106	32,578
Accrued Expenses	-	7,792	-	-	-	-
Short-Term Debt	-	54	245	10,936	-	-
Current Portion of Long-Term Debt	-	-	-	-	-	3,000
Current Portion of Leases	-	2,694	2,811	3,029	2,912	2,726
Current Income Taxes Payable	2,701	5,710	6,745	4,198	5,458	6,848
Other Current Liabilities	39,568	33,015	34,758	36,473	32,073	22,445
Total Current Liabilities	83,868	92,796	89,504	95,821	78,549	67,597
Long-Term Debt	-	26,915	28,198	12,677	2,400	1,965
Long-Term Leases	-	4,947	4,953	6,290	4,834	4,637
Long-Term Deferred Tax Liabilities	1,254	1,377	1,592	2,526	3,290	7,228
Other Long-Term Liabilities	34,425	3,002	2,365	4,742	5,020	23,043
Total Liabilities	120,831	130,329	127,883	123,133	95,303	106,208
Common Stock	8,791	8,777	8,702	8,672	8,525	8,366
Additional Paid-In Capital	9,374	9,854	9,789	9,370	8,954	8,746
Retained Earnings	252,938	240,029	238,071	290,477	270,757	273,422
Treasury Stock	-24,484	-1,018	-364	-718	-934	-1,033
Comprehensive Income & Other	42,358	48,413	37,781	29,687	20,283	13,364
Total Common Equity	288,977	306,055	293,979	337,488	307,585	302,865
Minority Interest	-723	-685	-683	-645	-535	-305
Shareholders' Equity	288,254	305,370	293,296	336,843	307,050	302,560
Total Liabilities & Equity	409,085	435,699	421,179	459,976	402,353	408,768
Total Debt	-	34,610	36,207	32,932	10,146	12,328
Net Cash (Debt)	84,441	59,972	21,696	50,082	52,742	79,102
Net Cash Growth	30.46%	176.42%	-56.68%	-5.04%	-33.32%	18.54%
Net Cash Per Share	235.98	162.91	56.00	125.06	131.73	197.63
Filing Date Shares Outstanding	349.15	356.09	369.88	393.3	399.82	399.53
Total Common Shares Outstanding	349.15	363.21	375.54	400.27	399.82	399.42
Working Capital	134,610	143,343	123,822	133,605	127,682	150,959
Book Value Per Share	827.65	842.64	782.82	843.15	769.31	758.26
Tangible Book Value	209,566	222,236	197,670	207,271	194,709	183,015
Tangible Book Value Per Share	600.21	611.87	526.36	517.83	486.99	458.20

Source: S&P Capital IQ. Standard template. Financial Sources.